Trial Profile
AGN-199201 for the Treatment of Erythema With Rosacea
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jul 2014
Price :
$35
*
At a glance
- Drugs Oxymetazoline (Primary)
- Indications Erythema
- Focus Therapeutic Use
- Sponsors Allergan
- 01 May 2014 New trial record